Results 181 to 190 of about 135,997 (338)

Prevalence and Characteristics of North American Indigenous Inflammatory Skin Disease: A Systematic Scoping Review

open access: yesInternational Journal of Dermatology, EarlyView.
This scoping review synthesizes evidence on atopic dermatitis (AD), psoriasis, and hidradenitis suppurativa in North American Indigenous peoples across 49 studies and 63 clinical trials. Findings reveal consistently high disease burden in AD, marked underrepresentation in trials and guidelines, and five evidence‐based recommendations to advance ...
Rachel Asiniwasis   +17 more
wiley   +1 more source

Correction to: A video of best practice recommendations for making botulinum toxin therapy safe during the COVID‐19 pandemic

open access: yes, 2022
Italian Botulinum Toxin Network-study group of Italian Society of Neurology   +4 more
core   +1 more source

Darier disease—A review highlighting new insights from the Darier Disease International Task Force

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
This review provides a global, clinically focused overview of DD, detailing cutaneous and extracutaneous manifestations, disease classification and severity scoring. It emphasizes early recognition, multidisciplinary management and practical guidance for dermatologists to apply evidence‐based care in diverse skin phototypes. Abstract Darier disease (DD)
Sofia Labbouz   +49 more
wiley   +1 more source

Use of Botulinum Toxin for the Treatment of Raynaud Phenomenon. [PDF]

open access: yesPlast Reconstr Surg Glob Open
Kalluri MH   +3 more
europepmc   +1 more source

Epidermal Growth Factor (EGF) and Botulinum Toxin (BTX); Can Paralysis Be A Bless?

open access: yes, 2016
Botulinum toxin (BTX) commercially known as Botox is produced by Clostridium Botulinum, it has many different subtypes. It is a relatively safe agent with very few local and systemic adverse effects, and is currently used in a wide range of medical ...
Bakr, Mahmoud M   +2 more
core  

Intravesical Botox: An Effective Therapy for Refractory Monosymptomatic Nocturnal Enuresis

open access: yesJournal of Paediatrics and Child Health, EarlyView.
ABSTRACT Aim Monosymptomatic nocturnal enuresis (MNE) significantly impacts many children, with substantial patient groups refractory to conventional first‐line treatments. Intravesical Botox is used for various refractory functional voiding disorders in children, but its efficacy in MNE has not been widely established.
Eliza Szwarcberg   +2 more
wiley   +1 more source

Evaluating the Role of Subcoronal Botulinum Toxin Injection in the Management of Premature Ejaculation. [PDF]

open access: yesClin Med Insights Case Rep
Hosseini SR   +8 more
europepmc   +1 more source

Platelet Levels Associated With Bleeding Risk for Dental Interventions: A Systematic Review

open access: yesOral Diseases, EarlyView.
ABSTRACT Objectives To evaluate evidence in relation to postoperative bleeding in humans aged ≥ 16 with preoperative platelet counts < 50,000/μL, compared to those above, undergoing dental interventions. Methods Quantitative synthesis without meta‐analysis was conducted through an electronic search conducted on Ovid MEDLINE and Embase from 1946 to ...
Guang Xu David Lim   +3 more
wiley   +1 more source

Botulinum Toxin Treatment of Stiff Person Syndrome-A Critical Review and Update. [PDF]

open access: yesToxins (Basel)
Tohidian AG   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy